These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 500299)

  • 1. Serum and ultradiafiltrate middle molecules in hemodialysed patients.
    Bozek P; Erben J; Zahradnik J; Dzúrik R
    Int Urol Nephrol; 1979; 11(3):223-8. PubMed ID: 500299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
    Válek A; Dzúrik R; Spustová V; Válková D
    Artif Organs; 1981; 4 Suppl():173-6. PubMed ID: 7295088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 4. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis therapy: 'think differently'.
    Perrone B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v1-2. PubMed ID: 17586840
    [No Abstract]   [Full Text] [Related]  

  • 6. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning].
    Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB
    Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752
    [No Abstract]   [Full Text] [Related]  

  • 7. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
    Rinaudo JB; Gallice P; Crevat A; Saingra S; Murisasco A
    Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle molecules in renal failure.
    Leber HW; Goubeaud G; Spiegelhalter R
    Ann Clin Biochem; 1979 Nov; 16(6):389-95. PubMed ID: 539797
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S; Barani R; Buzio C; Arisi L; Quaretti P
    Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, middle and large molecular substances].
    Gejyo F
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1550-4. PubMed ID: 3546560
    [No Abstract]   [Full Text] [Related]  

  • 11. Middle molecular weight substances and uremic polyneuropathy.
    Dukanović L; Petrović J; Potić J
    Acta Med Iugosl; 1990; 44(2):117-28. PubMed ID: 2162129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can the concentration of middle molecular substances in plasma contribute to the assessment of the adequacy of regular dialysis therapy?].
    Válek A; Spustová V; Lopot F; Erben J; Dzúrik R
    Cas Lek Cesk; 1984 May; 123(20):599-604. PubMed ID: 6467309
    [No Abstract]   [Full Text] [Related]  

  • 13. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 14. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis.
    Galli F; Beninati S; Benedetti S; Lentini A; Canestrari F; Tabilio A; Buoncristiani U
    Kidney Int Suppl; 2001 Feb; 78():S73-6. PubMed ID: 11168987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte transport of middle molecular substances.
    Gajdos M; Spustová V; Geryková M; Dzúrik R
    Proc Eur Dial Transplant Assoc; 1981; 18():183-7. PubMed ID: 7329966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anemia of chronic renal failure: erythropoiesis and serum inhibitor(s) of erythroid progenitor cells in uremia].
    Urushiyama M; Moriyama Y
    Rinsho Ketsueki; 1985 May; 26(5):668-73. PubMed ID: 4057581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.